Dergiler / Turkish Journal of Hematology / 2002 / Cilt: 19 - Sayı: 2

Endocrinologic late effects of chemoradiotherapy in pediatric acute leukemia

Sayfa
293–301
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Subclinic subtle primary and subclinic central hypothyroidism were found in 31.2%, impaired Sertoli and Leydig with Sertoli cell function in 66.66% of long-term survivors pediatric acute leukemia and testicular tissue was more sensitive to adverse effects of chemotherapy than ovarian tissue.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study intends to describe growth and endocrine disorders secondary to chemotherapy among long-term survivors of pediatric acute leukemia.
📊
Temel Bulgular & Veri:Sixteen patients including 14 ALL and 2 AML entered the study.
💡
Sonuç & Katkı:Conclusion: Subclinic subtle primary and subclinic central hypothyroidism were found in 31.2%, impaired Sertoli and Leydig with Sertoli cell function in 66.66% of long-term survivors pediatric acute leukemia and testicular tissue was more sensitive to adverse effects of chemotherapy than ovarian tissue.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Kemoterapi · adjuvan · Akut hastalık

Özet

This study intends to describe growth and endocrine disorders secondary to chemotherapy among long-term survivors of pediatric acute leukemia. Sixteen patients including 14 ALL and 2 AML entered the study. Four were females and 12 were males with the mean age of 17.38 ± 3.81 years. Following the completion of their therapy, the mean follow up period of the patients was 62.43 ± 41.11 months. Somatic growth, sexual maturation, hypothalamic- pituitary-thyroid axis and hypothalamic-pituitary-gonadal axis were evaluated in all the patients. Two out of 16 had pathologic short stature (12.5%) and 3 patients had enuchoid status (18.75%) with antrophometric measurements. Eleven patients had normal thyroid gland dimensions and homogeneous thyroid tissue on ultrasonographic examination. One patient had Ia and another four patients had Ib diffuse goitre according to WHO criteria. Two out of 16 patients were diagnosed as subclinic primary hypothyroidism (12.5%), and three of them were diagnosed as subclinic central hypoth yroidism (18.75%) according to TRH testing. Three patients were subclinic subtle central hypothyroidism. Thyroid auto-antibodies were in normal range in all patients. Eight patients (66.6%) out of 12 male subjects revealed impaired HHG axis. Hypergonadotropic hypogonadism (Leydig and Sertoli dysfunction) were observed in five of them and isolated Sertoli dysfunction was detected in three of them. Azoospermia was encountered in all patients with isolated Sertoli dysfunction. Testicular biopsy was obtained from only one of them and atrophic testicular tissue was detected. Female patients show normal pubertal development and gonadal functions. Conclusion: Subclinic subtle primary and subclinic central hypothyroidism were found in 31.2%, impaired Sertoli and Leydig with Sertoli cell function in 66.66% of long-term survivors pediatric acute leukemia and testicular tissue was more sensitive to adverse effects of chemotherapy than ovarian tissue.

🔖

Bu Makaleye Atıf Yap

GÖZDAŞOĞLU, S., AKSOYLAR, S., BERBEROĞLU, M., ÖCAL, G., ADIYAMAN, P., ÇAVDAR, A. O., BABACAN, E., ÜNAL, E., TAÇYILDIZ, N., YAVUZ, G. (2002). Endocrinologic late effects of chemoradiotherapy in pediatric acute leukemia. Turkish Journal of Hematology, Cilt: 19 - Sayı: 2, 293–301. https://ajindex.com/articles/413424

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Blatt J, Copeland DR, Bleyer WA. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. 2nd ed. Philadelphia: JB Lippincott Co, 1993:1091-107
  2. Shalet SM. Growth and endocrine sequelae following the treatment of childhood cancer. In: Brook CGD (ed). Clinical Pediatric Endocrinology. 3rd ed. Oxford. Blackwell Science Ltd, 1995:389-96
  3. Rappaport R, Thibaud E. Endocrine problems after cancer therapy. In: Lifshitz F (ed). Pediatric Endocri¬ nology. 3rd ed. New York: Marcel Dekker Inc, 1996:821-6
  4. Shalet SM, Krabbe S, Skakkeback NE. Growth and development in children treated for cancer. Hormone Research International Journal of Experiment and Clinical Endocrinology, 1998:53-125
  5. Neyzi O, Binyıldız P, Alp H. Türk çocuklarında büyüme gelişme normları I, tartı ve boy değerleri. 1st Tıp Fak Mecm 1978;41(Suppl):479
  6. Needlman RD. Growth and development. In: Behr- man RE, Kliegman RM, Arvin AM (eds). Nelson Textbook of Pediatrics: 15th ed. WB Philadelphia: Saunders Co, 1996:30-67
  7. Goodburn R. Immunometric assays. In: Williams DL,. Heinemann M (eds). Principle of Clinical Biochemistry. 2nd ed. Med Books, 1988:502-12. 7a. Koloğlu LB. Tiroid hastalıklarının tanısında faydalanılan bazı modern fonksiyon testlerinin uygulama prensipleri (isotopik ve nonisotopik yöntemler). Türkiye Klinikleri Tıp Bilimleri 1990; 10:366-74
  8. Marky I, Samuelsson BO, Mellander L, Karlberg J. Longitudinal growth in children with non-Hodgkin's lymphoma and children with acute lymphoblastic leukemia: Comparison between unirradiated and irradiated patients. Med and Pediatr Oncol 1991;19:96-9
  9. Marky I, Mellander L, Lannering B, Albertsson-Wikland K. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Med and Pediatr On¬ col 1991; 19:258-64
  10. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1998,25:561-7
  11. Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth hormone deficieny after treatment for acute lymphoblastic leukemia. Lancet 1987;l:190-3
  12. Yamada S, Ishii B, Okabe Y, et al. Growth retardation in childhood leukemia and lymphoma. Special referance to patients with CNS relapse. Am J of Pediatric Hemato/Oncol 1992;14:236-40
  13. Wallace WH. Late endocrine effects of cancer treatment in childhood. Colwopd House Medical Publications 1998:1-44
  14. Gözdasog